COLUMN GROUP III-A, LP
CIK 1668085 · last filed 2026-01-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.23B
Companies
4
Total Filings
13
Lifetime Open-Market Net
$199.83M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SRZNW | 10%+ Owner | 996,502 | $0.02 | $18.0K | $2.50M | 1 | 2026-01-15 |
| NGM BIOPHARMACEUTICALS INC (NGM) Delisted | 10%+ Owner | 11,203,333 | $1.54 | $17.25M | $47.33M | 10 | 2023-01-17 |
| TNYA | 10%+ Owner | 4,414,720 | $0.71 | $3.14M | $150.00M | 1 | 2022-11-23 |
| RVMD | 10%+ Owner | 7,977,384 | $153.87 | $1.23B | $0 | 1 | 2020-02-18 |
Recent Filings · Page 2 of 2
13 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-02-10 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +179,600 | $2.87M | EDGAR |
| 2019-10-24 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +17,548 | $209.4K | EDGAR |
| 2019-10-11 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +212,688 | $2.22M | EDGAR |
Showing 11–13 of 13
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.